[1] |
WANG Xi, YE Ting, NIE Min, WU Xueyan, MAO Jiangfeng.
Beneficial effects of vemurafenib on craniopharyngioma carrying BRAF-V600E mutation
[J]. Basic & Clinical Medicine, 2024, 44(6): 866-872.
|
[2] |
JIA Anna, GUO Jinxin, ZHANG Xuan, ZHAN Shijia, YU Yongbo, GUO Yongli, CHANG Yan.
Regulation of TMEFF1 on proliferation of neuroblastoma cell lines
[J]. Basic & Clinical Medicine, 2024, 44(5): 637-644.
|
[3] |
LEI Shaoyuan, LI Yulong, SUN Fei, LIU Hongjun, WU Yue, GUO Yansu.
The epidemiology and prediction of brain tumors incidence and mortality in China
[J]. Basic & Clinical Medicine, 2024, 44(4): 454-458.
|
[4] |
JIA Anna, ZHAN Shijia, ZHANG Xuan, GUO Jinxin, YU Yongbo, GUO Yongli, CHANG Yan.
Regulatory effect of C12ORF66 on viability of MYCN amplified high-risk neuroblastoma cells
[J]. Basic & Clinical Medicine, 2024, 44(3): 288-294.
|
[5] |
QIU Jiaxing, LIU Yuhan, GUO Hongjiang, ZHANG Diya, WANG Yucheng, JU Rui, GUO Lei.
Culture of glioblastoma U87 stem-like cells and identification of its metabolic phenotype and tumorigenic ability
[J]. Basic & Clinical Medicine, 2024, 44(1): 16-22.
|
[6] |
WANG Shi-zun, ZHANG Dan, GE Ming, FENG Hai-liang, LIU Yu-qin.
Establishment and identification of a medulloblastoma transplantable tumor strain PUMC-MBT1
[J]. Basic & Clinical Medicine, 2022, 42(9): 1339-1343.
|
[7] |
GUO Xiao-peng, XING Bing, MA Wen-bin.
Immune microenvironment and immunotherapy of pituitary adenomas
[J]. Basic & Clinical Medicine, 2022, 42(1): 173-178.
|
[8] |
FANG Huang-yi, YOU Chao-guo, PANG Chen, ZHANG Zhong-ding, ZHANG Zhe, KUANG Tong-shuai, SHENG Han-song.
Mechanism of in vitro sensitization of temozolomide to MGMT+ glioma cell line by FM19G11
[J]. Basic & Clinical Medicine, 2021, 41(4): 514-520.
|
[9] |
YANG Chang-li, TU Guo-long, XIA Ying.
Clinical diagnosis and treatment of bitaleral acoustic neurofibromatosis type 2: a retrospective analysis of 4 patients
[J]. Basic & Clinical Medicine, 2020, 40(12): 1677-1680.
|
[10] |
LI Jing, CUI Hong-wei, YANG Ling.
Advances of research in microRNA regulating reactive oxygen species in glioma
[J]. Basic & Clinical Medicine, 2020, 40(8): 1124-1129.
|
[11] |
SUN Mao-cang, LI Xin.
miR-107 inhibits the proliferation, migration and invasion of glioma cells in vitro
[J]. Basic & Clinical Medicine, 2020, 40(6): 784-789.
|
[12] |
ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei.
Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
[J]. Basic & Clinical Medicine, 2020, 40(4): 473-478.
|
[13] |
LI Jia-yi, XING Bing.
Research progress of immune checkpoint inhibitor related autoimmune hypophysitis
[J]. Basic & Clinical Medicine, 2020, 40(3): 403-406.
|
[14] |
Yu-Qing ZHANG wen liu.
ALDH18A1 regulates MYCN expression in neuroblastoma
[J]. Basic & Clinical Medicine, 2019, 39(8): 1141-1145.
|
[15] |
.
Dynamic expression of YTHDC1 in mice cerebellar development and human medulloblastoma
[J]. Basic & Clinical Medicine, 2019, 39(7): 1001-1006.
|